MLchartDataset catalogue

Patent · US5185439A · A · US

Acridinium ester labelling and purification of nucleotide probes

(11) Publication number
US5185439A
(21) Application number
07/332,939
(22) Filing date
1988-12-12
(30) Priority date
1987-10-05
(43) Publication date
1993-02-09
(45) Date of grant
1993-02-09
(51) IPC
C07H 21/00
(52) CPC
  • C07H Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids: 21/00
(73) Assignee
Gen Probe Inc
(72) Inventors
Lyle J. Arnold, Jr.; Norman C. Nelson
(54) Title
Acridinium ester labelling and purification of nucleotide probes
(57) Abstract

Methods for the construction, labelling and subsequent purification of nucleic acid probes containing primary amines with acridinium esters 4-(2-succinimidyloxycarbonyl-ethyl)phenyl-10-methylacridinium-9-carbox ylate fluorosulfonate). The method for attaching acridinium esters to probes uses high (0.1 to 50 mM) acridinium ester concentrations achieved using organic solvent in concentrations of 20% to 80% by volume, and may be carried out either in solution, or with one or the other of the acridinium ester or the probe suspended in solution. Purification (the separation of labelled probe from unlabelled probe and free label) involves (1) first removing most of the free acridinium ester label from probe using rapid separation techniques, then (2) removing substantially all remaining free label from the probe and separating labelled probe from unlabelled probe, involves specific applications of ion exchange, reverse phase or hydroxyapatite HPLC.

Full text
View on Google Patents

Claims (17)

  1. A method for labelling a nucleic acid probe having a first conjugation moiety, with an acridinium ester labelling reagent having a second conjugation moiety, including the step of: combining said labelling reagent and said nucleic acid probe so as to effectuate a labelling reagent concentration of approximately 0.1-50 mM to obtain acridinium ester labelled nucleic acid probes in high yield.
  2. A method as in claim 1 wherein the step is carried out in the pH range 7-9.
  3. A method as in claim 2 wherein the step is carried out in the temperature range 15-40 degrees Celsius.
  4. A method as in claim 1 or 2 or 3 wherein the step is carried out in solution.
  5. A method as in claim 1 or 2 or 3 wherein the step is carried out with said nucleic acid probe in solution and wherein said labelling reagent is suspended in solution.
  6. A method as in claim 1 or 2 or 3 wherein the step is carried out with said labelling reagent in solution and said nucleic acid probe is suspended in solution.
  7. A method for labelling a nucleic acid probe having a first conjugation moiety, with an acridinium ester labelling reagent having a second conjugation moiety, including the step of: combining said labelling reagent and said nucleic acid probe in a manner so as to effectuate a labelling reagent concentration of approximately 0.1-50 mM and an organic solvent concentration of approximately 20% to 80% by volume to obtain acridinium ester labelled nucleic acid probes in high yield.
  8. A method as in Claim 7 wherein the step is carried out in pH range 7-9.
  9. A method as in Claim 7 wherein the step is carried out in the temperature range 15-40 degrees Celsius.
  10. A method as in Claim 7 or 8 or 9 wherein the step is carried out in solution.
  11. A method as in Claim 7 or 8 or 9 wherein the step is carried out with said nucleic acid probe in solution and wherein said labelling reagent is suspended in solution.
  12. A method as in Claim 7 or 8 or 9 wherein the step is carried out with said labelling reagent in solution and said nucleic acid probe is suspended in solution.
  13. The method of claim 7 wherein said organic solvent is selected from the group consisting of DMSO, CH 3 CN, dimethyl formamide, dioxane, acetone and methanol.
  14. A method for labelling nucleic acid probes having a first conjugation moiety with an acridinium ester labelling reagent having a second conjugation moiety, including the steps of: combining said labelling reagent in approximately a 0.1-50 mM concentration; with an organic solvent in concentration of approximately 20% to 80% by volume to obtain acridinium ester labelled nucleic acid probes in high yield; quenching the unreacted labelling reagent.
  15. A method for labelling nucleic acid probes having a first conjugation moiety with an acridinium ester labelling reagent having a second conjugation moiety, including the steps of: combining said labelling reagent in approximately a 0.1-50 mM concentration with an organic solvent in a 20% to 80% concentration by volume to obtain acridinium ester labelled nucleic acid probes in high yield, wherein said first and second conjugation moieties are selected, respectively from the group of pairs consisting of: ##STR12## with an organic solvent in concentration of approximately 20% to 80% by to volume in acridinium ester labelled nucleic acid probes in high yield.
  16. A method for labelling nucleic acid probes having a first conjugation moiety with an N-hydroxysuccinimide-acridinium ester labelling reagent, comprising the step of combining said labelling reagent in approximately a 1-10 mM concentration with an organic solvent in concentation of approximately 20% to 80% by volume, to obtain acridinium ester labelled nucleic acid probes in high yield.
  17. A method for labelling nucleic acid probes having a first conjugation moiety with an acridinium ester-methoxyimidate labelling reagent, comprising the step of combining said labelling reaGent in approximately a 1-10 mM concentration with an organic solvent in concentration of approximately 20% to 80% by volume, to obtain acridinium ester labelled nucleic acid probes in high yield.

Description

This is a continuation-in-part of application Ser. No. 105,080 filed Oct. 5, 1987, now abandoned.

The invention relates to methods and compositions for attaching detectable labels to diagnostic reagents. More specifically, it pertains to the labelling and purification of nucleotide probes with chemiluminescent acridinium esters for use in diagnostic hybridization assays.

In the last twenty years, a wide variety of agents have been used as labels in clinical diagnostic and research assays. More recently, hybridization assays have been developed for sensitively detecting the presence of unique polynucleotide sequences. Typically, in such assays, a nucleotide multimer (probe) is labelled with an atom or group which can be readily detected.

When the labelled probe is exposed to a test sample suspected of containing a target nucleotide sequence, under hybridizing conditions, the target will hybridize with any such labelled probe. The presence of the target sequence in the sample can be determined qualitatively, or quantatively usually by separating hybridized and non-hybridized probe, then determining the amount of labelled probe which hybridized, either by determining the presence of label in probe hybrids, or by determining the quantity of label in non-hybridized probes.

Historically, radioactive labels were used. However, due to health hazards and difficulties in handling, non-isotopic labels were later developed. Such labels include those whose presence is determined either directly or indirectly. Examples of direct labels include chemiluminescent, fluorescent, or spectroscopically detectable labels.

Citations (10)

  • US4136182A
  • GB2112779A
  • US4737454A
  • US4739044A
  • EP0210449A2
  • EP0212951A2
  • EP0231495B1
  • EP0233053A2
  • US5030557A
  • US4935263A
Record as JSON
{
  "publication_number": "US5185439A",
  "country": "US",
  "kind": "A",
  "title": "Acridinium ester labelling and purification of nucleotide probes",
  "abstract": "Methods for the construction, labelling and subsequent purification of nucleic acid probes containing primary amines with acridinium esters 4-(2-succinimidyloxycarbonyl-ethyl)phenyl-10-methylacridinium-9-carbox ylate fluorosulfonate). The method for attaching acridinium esters to probes uses high (0.1 to 50 mM) acridinium ester concentrations achieved using organic solvent in concentrations of 20% to 80% by volume, and may be carried out either in solution, or with one or the other of the acridinium ester or the probe suspended in solution. Purification (the separation of labelled probe from unlabelled probe and free label) involves (1) first removing most of the free acridinium ester label from probe using rapid separation techniques, then (2) removing substantially all remaining free label from the probe and separating labelled probe from unlabelled probe, involves specific applications of ion exchange, reverse phase or hydroxyapatite HPLC.",
  "claims": [
    "1. A method for labelling a nucleic acid probe having a first conjugation moiety, with an acridinium ester labelling reagent having a second conjugation moiety, including the step of: combining said labelling reagent and said nucleic acid probe so as to effectuate a labelling reagent concentration of approximately 0.1-50 mM to obtain acridinium ester labelled nucleic acid probes in high yield.",
    "2. A method as in claim 1 wherein the step is carried out in the pH range 7-9.",
    "3. A method as in claim 2 wherein the step is carried out in the temperature range 15-40 degrees Celsius.",
    "4. A method as in claim 1 or 2 or 3 wherein the step is carried out in solution.",
    "5. A method as in claim 1 or 2 or 3 wherein the step is carried out with said nucleic acid probe in solution and wherein said labelling reagent is suspended in solution.",
    "6. A method as in claim 1 or 2 or 3 wherein the step is carried out with said labelling reagent in solution and said nucleic acid probe is suspended in solution.",
    "7. A method for labelling a nucleic acid probe having a first conjugation moiety, with an acridinium ester labelling reagent having a second conjugation moiety, including the step of: combining said labelling reagent and said nucleic acid probe in a manner so as to effectuate a labelling reagent concentration of approximately 0.1-50 mM and an organic solvent concentration of approximately 20% to 80% by volume to obtain acridinium ester labelled nucleic acid probes in high yield.",
    "8. A method as in Claim 7 wherein the step is carried out in pH range 7-9.",
    "9. A method as in Claim 7 wherein the step is carried out in the temperature range 15-40 degrees Celsius.",
    "10. A method as in Claim 7 or 8 or 9 wherein the step is carried out in solution.",
    "11. A method as in Claim 7 or 8 or 9 wherein the step is carried out with said nucleic acid probe in solution and wherein said labelling reagent is suspended in solution.",
    "12. A method as in Claim 7 or 8 or 9 wherein the step is carried out with said labelling reagent in solution and said nucleic acid probe is suspended in solution.",
    "13. The method of claim 7 wherein said organic solvent is selected from the group consisting of DMSO, CH 3 CN, dimethyl formamide, dioxane, acetone and methanol.",
    "14. A method for labelling nucleic acid probes having a first conjugation moiety with an acridinium ester labelling reagent having a second conjugation moiety, including the steps of: combining said labelling reagent in approximately a 0.1-50 mM concentration; with an organic solvent in concentration of approximately 20% to 80% by volume to obtain acridinium ester labelled nucleic acid probes in high yield; quenching the unreacted labelling reagent.",
    "15. A method for labelling nucleic acid probes having a first conjugation moiety with an acridinium ester labelling reagent having a second conjugation moiety, including the steps of: combining said labelling reagent in approximately a 0.1-50 mM concentration with an organic solvent in a 20% to 80% concentration by volume to obtain acridinium ester labelled nucleic acid probes in high yield, wherein said first and second conjugation moieties are selected, respectively from the group of pairs consisting of: ##STR12## with an organic solvent in concentration of approximately 20% to 80% by to volume in acridinium ester labelled nucleic acid probes in high yield.",
    "16. A method for labelling nucleic acid probes having a first conjugation moiety with an N-hydroxysuccinimide-acridinium ester labelling reagent, comprising the step of combining said labelling reagent in approximately a 1-10 mM concentration with an organic solvent in concentation of approximately 20% to 80% by volume, to obtain acridinium ester labelled nucleic acid probes in high yield.",
    "17. A method for labelling nucleic acid probes having a first conjugation moiety with an acridinium ester-methoxyimidate labelling reagent, comprising the step of combining said labelling reaGent in approximately a 1-10 mM concentration with an organic solvent in concentration of approximately 20% to 80% by volume, to obtain acridinium ester labelled nucleic acid probes in high yield."
  ],
  "description_excerpt": "This is a continuation-in-part of application Ser. No. 105,080 filed Oct. 5, 1987, now abandoned.\n\nThe invention relates to methods and compositions for attaching detectable labels to diagnostic reagents. More specifically, it pertains to the labelling and purification of nucleotide probes with chemiluminescent acridinium esters for use in diagnostic hybridization assays.\n\nIn the last twenty years, a wide variety of agents have been used as labels in clinical diagnostic and research assays. More recently, hybridization assays have been developed for sensitively detecting the presence of unique polynucleotide sequences. Typically, in such assays, a nucleotide multimer (probe) is labelled with an atom or group which can be readily detected.\n\nWhen the labelled probe is exposed to a test sample suspected of containing a target nucleotide sequence, under hybridizing conditions, the target will hybridize with any such labelled probe. The presence of the target sequence in the sample can be determined qualitatively, or quantatively usually by separating hybridized and non-hybridized probe, then determining the amount of labelled probe which hybridized, either by determining the presence of label in probe hybrids, or by determining the quantity of label in non-hybridized probes.\n\nHistorically, radioactive labels were used. However, due to health hazards and difficulties in handling, non-isotopic labels were later developed. Such labels include those whose presence is determined either directly or indirectly. Examples of direct labels include chemiluminescent, fluorescent, or spectroscopically detectable labels.",
  "cpc": [
    "C07H 21/00"
  ],
  "ipc": [
    "C07H 21/00"
  ],
  "assignees": [
    "Gen Probe Inc"
  ],
  "inventors": [
    "Lyle J. Arnold, Jr.",
    "Norman C. Nelson"
  ],
  "filing_date": "1988-12-12",
  "publication_date": "1993-02-09",
  "grant_date": "1993-02-09",
  "priority_date": "1987-10-05",
  "application_number": "US-33293988-A",
  "family_id": "26802243",
  "cited_by_count": 240,
  "citations": [
    "US4136182A",
    "GB2112779A",
    "US4737454A",
    "US4739044A",
    "EP0210449A2",
    "EP0212951A2",
    "EP0231495B1",
    "EP0233053A2",
    "US5030557A",
    "US4935263A"
  ]
}

Record 7,189 of 8,000 in Patents full text (MLC-0201). Request the full dataset.